Loading
A phase 3 trial of Fentanyl in Breast cancer, run by M.D. Anderson Cancer Center, completed.
Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery is a phase 3 interventional study registered as NCT00542542 by M.D. Anderson Cancer Center, with 89 participants recorded, started 2007-09 and reaching its primary completion in 2014-03. Interventions recorded: Paravertebral Block, Propofol, Fentanyl, Ropivacaine, Midazolam. Conditions recorded: Breast Cancer.
Linked to the drug Fentanyl because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/